STOCK TITAN
  1. Home
  2. Sec-filings
  3. RDHL
  4. [EFFECT] Redhill Biopharma Ltd. SEC Filing

[EFFECT] Redhill Biopharma Ltd. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 2, 2025 4:00 P.M.
Form: F-1
CIK: 0001553846
Company Name: RedHill Biopharma Ltd.
File Number: 333-288324

Source: View Original Filing on SEC EDGAR

Stock RDHL logo
Redhill Biopharm

NASDAQ:RDHL

RDHL Rankings

#6519 Ranked by Market Cap
N/A Ranked by Dividends

RDHL Latest News

Jan 5, 2026
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
Jan 5, 2026
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
Dec 15, 2025
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
Dec 15, 2025
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
Dec 1, 2025
RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement

RDHL Latest SEC Filings

Jan 27, 2026
[6-K] RedHill Biopharma Ltd. Current Report (Foreign Issuer)
Jan 22, 2026
[F-1/A] RedHill Biopharma Ltd. Amended Foreign Issuer IPO Registration
Jan 22, 2026
[6-K] RedHill Biopharma Ltd. Current Report (Foreign Issuer)
Dec 15, 2025
[6-K] RedHill Biopharma Ltd. Current Report (Foreign Issuer)
Nov 26, 2025
[424B5] RedHill Biopharma Ltd. Prospectus Supplement (Debt Securities)

RDHL Stock Data

6.70M
5.09M
2.69%
3.33%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Tel Aviv